Pharmaceuticals, namely pharmaceutical preparations for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; empty capsules for pharmaceuticals; lacteal flour for babies; dietary supplements for humans for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; dietetic beverages adapted for medical purposes, namely dietetic beverages for medical use for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; dietetic food adapted for medical purpose, namely dietetic food for medical use for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; beverages for babies; food for babies; dietary supplements for animals, namely animal feed supplements and protein supplements for animals

Non-medicated skin care preparation containing ferulic acid and retinol; skin care preparations, namely, skin peels containing ferulic acid and retinol.

Perfumery; Cosmetic preparations for baths, namely, cosmetic bath oils, cosmetic bath powder, cosmetic bath salts; Shower creams; Shower gels; Skin care, namely, skin cleansers; Facial beauty masks; Face and body lotions, face and body creams, body moisturizing milks, body milks, beauty milks, petroleum jelly for cosmetic purposes; Body moisturisers; Beauty creams, other than for medical purposes;

Optical spectacles; Sunglasses; Optical eye glasses; Pince-nez cords; Spectacle cases; Frames for spectacles and sunglasses; Parts for spectacles, namely, spectacle holders, chains for eyeglasses, frames for spectacles; Cases for eyeglasses and sunglasses; Spectacle cases; Cases for mobile phones; Bags and cases adapted or shaped to carry MP3 players; Computer carrying cases; Laptop cases; Tablet personal computer cases; Bags and cases adapted or shaped to contain cameras and video cameras; Mouse mats; Bags and cases adapted or shaped to carry GPS systems; Electronic organizers, electronic notepads;

Liquid carbon dioxide and liquid nitrogen.

Liquified natural gas.

Liquid carbon dioxide and liquid nitrogen.

Liquified natural gas.

Men's, ladies' and children's pants, slacks and shorts.

Chemical substances used in manufactures, namely, ingredients and mineral products used in the manufacture of fluxes; fluxes, namely welding fluxes.